Clinical trials
Shock, Septic trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 4 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Charles University, Czech Republic | 4 |
| University Hospital Ostrava | 4 |
| Anders Perner, MD, PhD | 1 |
| AstraZeneca | 1 |
| Brno University Hospital | 1 |
| Eisai Inc. | 1 |
| Eli Lilly and Company | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| GlaxoSmithKline | 1 |
| Maastricht University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Septic | 19 |
| Sepsis | 13 |
| Hypoxia | 2 |
| Respiratory Distress Syndrome | 2 |
| Respiratory Insufficiency | 2 |
| Systemic Inflammatory Response Syndrome | 2 |
| Acid-Base Imbalance | 1 |
| Acidosis, Respiratory | 1 |
| Acute Kidney Injury | 1 |
| Alkalosis, Respiratory | 1 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.